samedan logo
 
 
 
spacer
home > ebr > summer 2019 > the factory for next- generation therapies
PUBLICATIONS
European Biopharmaceutical Review

The Factory for Next- Generation Therapies

This edition of European Biopharmaceutical Review features articles that support the current momentum of discovery and development in a number of advanced cell and medicinal therapy areas. Unarguably, this is where medicine is headed. In terms of the latest advancements in cell-based therapies and cancer, we can now extract, reprogramme, expand, and reintroduce a patients’ own ‘supercharged’ T cells to fight B cell lymphoblastic leukaemia and B cell non-Hodgkin’s lymphoma through chimeric antigen receptor (CAR) T cell therapy. Could we have imagined this progress, or even the entire field of immunoncology, as it now stands 30 years ago?

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

Reify Health Raises $220 Million to Eliminate Waiting in Clinical Trials

Reify Health today announced a $220 million Series C funding round led by Coatue Management, joined by ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures.
More info >>

White Papers

Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor

Eppendorf

The number of bioprocess applications for microalgae has increased in recent years, particularly in the fi eld of biofuel production. The combination of the New Brunswick CelliGen 310 stirred-tank bioreactor and the DASGIP LED Illumination System creates a bioreactor setup which is capable of supporting high density microalgal growth. Using the stand-alone Eppendorf DASGIP PBR4 Module, LED illumination spectra and intensities can be controlled for optimal support of all types of chlorophylls and carotenoids. For this study in which high density culture of up to 1.5 x 107 cells/mL was achieved, the unicellular freshwater alga, Dunaliella tertiolecta, was used.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement